Cytochrome P450 structure–function: insights from molecular dynamics simulations

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug metabolism reviews (Softcover ed.)

• Publication date

  2016-05-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1080/03602532.2016.1178771PMID 27167388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding*

  2015cited by this paper
• Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation

  2015cited by this paper
• The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.

  2015cited by this paper
• Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures.

  2015influential reference
• Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.

  2015influential reference
• CYP2E1 hydroxylation of aniline involves negative cooperativity.

  2014influential reference
• Including ligand‐induced protein flexibility into protein tunnel prediction

  2014cited by this paper
• Ensemble Generation and the Influence of Protein Flexibility on Geometric Tunnel Prediction in Cytochrome P450 Enzymes

  2014cited by this paper
• Molecular dynamics simulations: from structure function relationships to drug discovery

  2014cited by this paper
• Screening proteins for NMR suitability.

  2014cited by this paper
• Evaluation of Influence of Single Nucleotide Polymorphisms in Cytochrome P450 2B6 on Substrate Recognition Using Computational Docking and Molecular Dynamics Simulation

  2014cited by this paper
• Concurrent Cooperativity and Substrate Inhibition in the Epoxidation of Carbamazepine by Cytochrome P450 3A4 Active Site Mutants Inspired by Molecular Dynamics Simulations

  2014cited by this paper
• Function and dynamics of macromolecular complexes explored by integrative structural and computational biology.

  2014cited by this paper
• Conformational diversity and ligand tunnels of mammalian cytochrome P450s

  2013influential reference
• Correction: Distal Effect of Amino Acid Substitutions in CYP2C9 Polymorphic Variants Causes Differences in Interatomic Interactions against (S)-Warfarin

  2013influential reference
• Structure of pyrazole derivatives impact their affinity, stoichiometry, and cooperative interactions for CYP2E1 complexes.

  2013influential reference
• Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues.

  2013cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• What makes a P450 tick?

  2013cited by this paper
• Structural Diversity of Eukaryotic Membrane Cytochrome P450s*

  2013cited by this paper
• Distal Effect of Amino Acid Substitutions in CYP2C9 Polymorphic Variants Causes Differences in Interatomic Interactions against (S)-Warfarin

  2013cited by this paper
• Quantum Mechanics/Molecular Mechanics Modeling of Regioselectivity of Drug Metabolism in Cytochrome P450 2C9

  2013cited by this paper
• Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.

  2012cited by this paper
• Dynamics and hydration of the active sites of mammalian cytochromes P450 probed by molecular dynamics simulations.

  2012cited by this paper
• CYP2E1 Metabolism of Styrene Involves Allostery

  2012influential reference
• Cytochrome P450 3A4 Inhibition by Ketoconazole: Tackling the Problem of Ligand Cooperativity Using Molecular Dynamics Simulations and Free-Energy Calculations

  2012cited by this paper
• The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin

  2012cited by this paper
• Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.

  2012cited by this paper
• Missing fragments: detecting cooperative binding in fragment-based drug design.

  2012cited by this paper
• Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen.

  2012cited by this paper
• Plasticity of CYP2B enzymes: structural and solution biophysical methods.

  2012cited by this paper
• CYP 2 E 1 Metabolism of Styrene Involves Allostery

  2012influential reference
• Refinement of protein structure homology models via long, all‐atom molecular dynamics simulations

  2012cited by this paper
• Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9.

  2012cited by this paper
• Membrane Position of Ibuprofen Agrees with Suggested Access Path Entrance to Cytochrome P450 2C9 Active Site

  2011cited by this paper
• Reduced catalytic activity of human CYP2C9 natural alleles for gliclazide: molecular dynamics simulation and docking studies.

  2011cited by this paper
• Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.

  2011influential reference
• Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures.

  2011cited by this paper
• Exploration of the binding of proton pump inhibitors to human P450 2C9 based on docking and molecular dynamics simulation

  2011cited by this paper
• Functional Characterization of CYP2B6 Allelic Variants in Demethylation of Antimalarial Artemether

  2011cited by this paper
• Long-Range Effects of a Peripheral Mutation on the Enzymatic Activity of Cytochrome P450 1A2

  2011cited by this paper
• Application of Homology Modeling to Generate CYP1A1 Mutants with Enhanced Activation of the Cancer Chemotherapeutic Prodrug Dacarbazine

  2011cited by this paper
• A Negative Cooperativity Mechanism of Human CYP2E1 Inferred from Molecular Dynamics Simulations and Free Energy Calculations

  2011cited by this paper
• On the deduction and analysis of singlet and two-state gating-models from the static structures of mammalian CYP450.

  2011influential reference
• Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9

  2011influential reference
• Using Theory to Reconcile Experiment: The Structural and Thermodynamic Basis of Ligand Recognition by Phenylethanolamine N-Methyltransferase (PNMT).

  2011cited by this paper
• Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode*

  2010influential reference
• Plasticity of Cytochrome P450 2B4 as Investigated by Hydrogen-Deuterium Exchange Mass Spectrometry and X-ray Crystallography*

  2010cited by this paper
• Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis

  2010influential reference
• Prediction and analysis of the modular structure of cytochrome P450 monooxygenases

  2010cited by this paper
• Analysis of binding modes of ligands to multiple conformations of CYP3A4.

  2010cited by this paper
• Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations.

  2010cited by this paper
• Role of Water in Molecular Docking Simulations of Cytochrome P450 2D6

  2010cited by this paper
• Homology modeling and molecular dynamics of CYP1A1 and CYP2B1 to explore the metabolism of aryl derivatives by docking and experimental assays.

  2010influential reference
• Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning.

  2009cited by this paper
• The Cytochrome P450 Homepage

  2009cited by this paper
• CHARMM: The biomolecular simulation program

  2009cited by this paper
• Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.

  2009cited by this paper
• Multiple-ligand binding in CYP2A6: probing mechanisms of cytochrome P450 cooperativity by assessing substrate dynamics.

  2008cited by this paper
• Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

  2008cited by this paper
• Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking.

  2008cited by this paper
• Cytochrome p450 and chemical toxicology.

  2008cited by this paper
• CYP2E1 Substrate Inhibition

  2008cited by this paper
• Analysis of CYP2D6 substrate interactions by computational methods.

  2008influential reference
• Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.

  2008cited by this paper
• Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.

  2007cited by this paper
• Free energies of binding of R- and S-propranolol to wild-type and F483A mutant cytochrome P450 2D6 from molecular dynamics simulations

  2007cited by this paper
• Possible Pathway(s) of Metyrapone Egress from the Active Site of Cytochrome P450 3A4: A Molecular Dynamics Simulation

  2007cited by this paper
• The ins and outs of cytochrome P450s.

  2007influential reference
• Polymorphic Variants of CYP2C9: Mechanisms Involved in Reduced Catalytic Activity

  2007influential reference
• Dynamics of water molecules in the active-site cavity of human cytochromes P450.

  2007cited by this paper
• Structural dynamics of the cooperative binding of organic molecules in the human cytochrome P450 3A4.

  2007cited by this paper
• Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole

  2006cited by this paper
• On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study.

  2006cited by this paper
• Structural basis for ligand promiscuity in cytochrome P450 3A4

  2006cited by this paper
• POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION

  2005cited by this paper
• Crystal Structure of Human Cytochrome P450 2D6*

  2005influential reference
• The Amber biomolecular simulation programs

  2005cited by this paper
• GROMACS: Fast, flexible, and free

  2005cited by this paper
• Scalable molecular dynamics with NAMD

  2005cited by this paper
• CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions: Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 Variant

  2005cited by this paper
• Cytochrome P450: nature's most versatile biological catalyst.

  2005cited by this paper
• Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics.

  2005cited by this paper
• The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent.

  2005cited by this paper
• Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?

  2005cited by this paper
• Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation.

  2005cited by this paper
• Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone

  2004cited by this paper
• The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution*

  2004cited by this paper
• A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6

  2004cited by this paper
• Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution

  2004cited by this paper
• Discovery of a novel binding trench in HIV integrase.

  2004cited by this paper
• The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution*

  2004cited by this paper
• Refinement of homology‐based protein structures by molecular dynamics simulation techniques

  2004cited by this paper
• Six Novel Nonsynonymous CYP1A2 Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes

  2004cited by this paper
• Analysis of Differential Substrate Selectivities of CYP2B6 and CYP2E1 by Site-Directed Mutagenesis and Molecular Modeling

  2003cited by this paper
• Crystal structure of human cytochrome P450 2C9 with bound warfarin

  2003influential reference
• Molecular dynamics simulations of metalloproteins.

  2003cited by this paper
• Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine.

  2003cited by this paper
• An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution

  2003cited by this paper
• Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine

  2002cited by this paper

• Next-generation metabolic models informed by biomolecular simulations.

  2025cites this paper
• Interaction of cytochrome P450 3A4 with cannabinoids and the drug darifenacin

  2025cites this paper
• Cytochrome P450 F‐helix N204H mutation in CYP2C9.57 genetic variant reveals non‐typical ligand binding properties

  2025cites this paper
• Molecular dynamics simulations of cytochrome P450 aromatases reveal structural variances across the cat family.

  2025cites this paper
• Interactions of Linalool and Linalyl Acetate with Selected Dog Cytochrome P450 (CYP) Proteins Identified by In Silico Drug Discovery Followed by Molecular Docking Analysis

  2025cites this paper
• Engineering a 7β-hydroxylase from fusarium longipes for enhancement of ursodeoxycholic acid production.

  2025cites this paper
• Artificial intelligence and computational methods in human metabolism research: A comprehensive survey

  2025cites this paper
• Computational studies on human cytochrome P450: advancing insights into drug metabolism

  2025cites this paper
• Systematic Investigation of CYP3A4 Using Side-by-Side Comparisons of Apo, Active Site, and Allosteric-Bound States.

  2025cites this paper
• Theoretical Study on the Metabolic Mechanism of Heptachlor in Human Cytochrome P450 Enzymes

  2025influential citation
• Amebicidal and Antiadhesion Activities of Knema retusa Extract Against Acanthamoeba triangularis T4 Genotype on Contact Lenses and Modeling Simulation of Its Main Compound, E2N, Against Acanthamoeba Beta-Tubulin

  2025cites this paper
• Transcriptome analysis reveals the different toxic mechanism of three HBCD diastereoisomers to Brachionus plicatilis based on chemical defensome.

  2025cites this paper
• Costs of molecular adaptation to the chemical exposome: a focus on xenobiotic metabolism pathways

  2024cites this paper
• Computational journey to unveil organophosphorothioate pesticides' metabolism: A focus on chlorpyrifos and CYP2C19 mutational landscape.

  2024cites this paper
• Deep mutational scanning of CYP2C19 in human cells reveals a substrate specificity-abundance tradeoff.

  2024cites this paper
• Cytochrome P450 Enzyme Design by Constraining the Catalytic Pocket in a Diffusion Model

  2024cites this paper
• Small angle X-ray scattering analysis of thermophilic cytochrome P450 CYP119 and the effects of the N-terminal histidine tag.

  2024cites this paper
• Assessing the role of residue Phe108 of cytochrome P450 3A4 in allosteric effects of midazolam metabolism.

  2024cites this paper
• Water Exchange from the Buried Binding Sites of Cytochrome P450 Enzymes 1A2, 2D6, and 3A4 Correlates with Conformational Fluctuations

  2024cites this paper
• Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

  2023cites this paper
• Les effets toxiques induits par l’adaptation à l’environnement chimique : le double rôle du récepteur de la dioxine

  2023cites this paper
• Computational and artificial intelligence-based approaches for drug metabolism and transport prediction.

  2023cites this paper
• The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidation

  2023cites this paper
• Deep mutational scanning of CYP2C19 reveals a substrate specificity-abundance tradeoff

  2023cites this paper
• Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5

  2023cites this paper
• Pb exposure causes non-linear accumulation of Pb in D. melanogaster controlled by metallothionein B and exerts ecological effects.

  2023cites this paper
• Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations

  2023cites this paper
• Regio‐ and stereo‐selective 1β‐hydroxylation of lithocholic acid by cytochrome P450 BM3 mutants

  2023cites this paper
• Therapeutic treatments for diabetes mellitus-induced liver injury by regulating oxidative stress and inflammation

  2023cites this paper
• Prediction of Sites of Metabolism of CYP3A4 Substrates Utilizing Docking-Derived Geometric Features

  2023cites this paper
• Bioefficacy of Nga-Mon (Perilla frutescens) Fresh and Dry Leaf: Assessment of Antioxidant, Antimutagenicity, and Anti-Inflammatory Potential

  2023cites this paper
• Cytochrome P450 superfamily in spotted sea bass: Genome-wide identification and expression profiles under trichlorfon and environmental stresses.

  2023cites this paper
• Exploration of the binding of antifungal drugs to human P450 2C9 based on docking and molecular dynamics simulation

  2023cites this paper
• Comprehensive in vitro and in silico assessments of metabolic capabilities of 24 genomic variants of CYP2C19 using two different substrates

  2023cites this paper
• Molecular Basis of the Recognition of Cholesterol by Cytochrome P450 46A1 along the Major Access Tunnel.

  2022cites this paper
• In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes

  2022cites this paper
• Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning.

  2022cites this paper
• Effect of transgenic cotton lines expressing dsAgCYP6CY3-P1 on the growth and detoxification ability of Aphis gossypii Glover.

  2022cites this paper
• A gene cluster in Ginkgo biloba encodes unique multifunctional cytochrome P450s that initiate ginkgolide biosynthesis

  2022cites this paper
• Computer-Aided (In Silico) Modeling of Cytochrome P450-Mediated Food–Drug Interactions (FDI)

  2022cites this paper
• Designing Artificial Metalloenzymes by Tuning of the Environment beyond the Primary Coordination Sphere.

  2022cites this paper
• A Deep Dive into the Conformational Dynamics of CYP3A4 : Understanding the Binding of Homotropic and Non‐homotropic Ligands for Mitigating Drug‐Drug interaction (DDI)

  2022cites this paper
• Identification of Novel Molecular Targets of Four Microcystin Variants by High-Throughput Virtual Screening

  2022cites this paper
• Prediction of Drug Metabolism: Use of Structural Biology and In Silico Tools

  2021cites this paper
• Molecular probes for human cytochrome P450 enzymes: Recent progress and future perspectives

  2021cites this paper
• Massively parallel characterization of CYP2C9 variant enzyme activity and abundance

  2021cites this paper
• Fluorescent probes for the detection and imaging of Cytochrome P450

  2021cites this paper
• CityApps: A bioinformatics tool for predicting the key residues of enzymes weakly interacting with monovalent metal ions

  2021cites this paper
• St John’s wort (Hypericum perforatum L)

  2021cites this paper
• Perspective of structural flexibility on selective inhibition towards CYP1B1 over CYP1A1 by α-naphthoflavone analogs.

  2021cites this paper
• Fukinolic acid and cimicifugic acids: a review

  2021cites this paper
• Catalytic approach to in vivo metabolism of atractylenolide III using biomimetic iron–porphyrin complexes

  2021cites this paper
• Metabolism of 6:2 Fluorotelomer Alcohol by CYP 2A6

  2021cites this paper
• Quantitative analysis of proteomic profiling in constipation colon biopsies

  2020cites this paper
• Toxicity of Dithiothreitol (DTT) to Drosophila melanogaster

  2020cites this paper
• Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6

  2020cites this paper
• Deciphering Reaction Determinants of Altered-Activity CYP2D6 Variants by Well-Tempered Metadynamics Simulation and QM/MM Calculations

  2020cites this paper
• Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity

  2020cites this paper
• Roles of the variable P450 substrate recognition sites SRS1 and SRS6 in esfenvalerate metabolism by CYP6AE subfamily enzymes in Helicoverpa armigera.

  2020cites this paper
• Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51

  2020cites this paper
• Interaction Modes of Microsomal Cytochrome P450s with Its Reductase and the Role of Substrate Binding

  2020cites this paper
• Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen

  2020cites this paper
• How do mutations affect the structural characteristics and substrate binding of CYP21A2? An investigation by molecular dynamics simulations.

  2020cites this paper
• THE ROLE OF CYP2E1 POLYMORPHISM IN THE ACTIVATION OF PROCARCINOGEN METABOLISM OF NASOPHARYNGEAL CARCINOMA

  2019cites this paper
• Molecular Basis for Metabolic Regioselectivity and Mechanism of Cytochrome P450s toward Carcinogenic 4-(Methylnitrosamino)-(3-pyridyl)-1-butanone (NNK).

  2019cites this paper
• Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome

  2019cites this paper
• Evaluation of the time‐dependent antiproliferative activity and liver microsome stability of 3 phenyl 4‐(2‐oxo‐3‐alkylimidazolidin‐1‐yl)benzenesulfonates as promising CYP1A1‐dependent antimicrotubule prodrugs

  2019cites this paper
• Study of the hepatic stability and the therapeutic potential of novel antimitotic prodrugs selective for CYP1A1-expressing breast cancer cells

  2019cites this paper
• Transcriptome-Based Identification and Molecular Evolution of the Cytochrome P450 Genes and Expression Profiling under Dimethoate Treatment in Amur Stickleback (Pungitius sinensis)

  2019cites this paper
• Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib

  2019cites this paper
• From Endogenous Compounds as Biomarkers to Plasma‐Derived Nanovesicles as Liquid Biopsy; Has the Golden Age of Translational Pharmacokinetics‐Absorption, Distribution, Metabolism, Excretion‐Drug–Drug Interaction Science Finally Arrived?

  2019influential citation
• P450 Monooxygenases Enable Rapid Late‐Stage Diversification of Natural Products via C−H Bond Activation

  2019cites this paper
• Can multiscale simulations unravel the function of metallo-enzymes to improve knowledge-based drug discovery?

  2019cites this paper
• Computational Prediction of the Site(s) of Metabolism and Binding Modes of Protein Kinase Inhibitors Metabolized by CYP3A4

  2019cites this paper
• Spin Interconversion of Heme-Peroxo-Copper Complexes Facilitated by Intramolecular Hydrogen-Bonding Interactions.

  2019cites this paper
• Dynamic Effects of CYP2D6 Genetic Variants in a Set of Poor Metaboliser Patients with Infiltrating Ductal Cancer Under Treatment with Tamoxifen

  2019cites this paper
• The HNF1α-Regulated LncRNA HNF1α-AS1 Is Involved in the Regulation of Cytochrome P450 Expression in Human Liver Tissues and Huh7 Cells

  2019cites this paper
• Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4

  2019cites this paper
• Cytochrome P450-dependent reactive oxygen species (ROS) production contributes to Mn3O4 nanoparticle-caused liver injury

  2018cites this paper
• Evaluation of modafinil as a perpetrator of metabolic drug–drug interactions using a model informed cocktail reaction phenotyping trial protocol

  2018cites this paper
• Membrane-attached mammalian cytochromes P450: An overview of the membrane's effects on structure, drug binding, and interactions with redox partners.

  2018cites this paper
• Investigation of structure and function of mitochondrial alcohol dehydrogenase isozyme III from Komagataella phaffii GS115.

  2018cites this paper
• Substrate mediated redox partner selectivity of cytochrome P450.

  2018cites this paper
• Enzymatic Late-Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groups.

  2018cites this paper
• Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population

  2018cites this paper
• Molecular Binding Kinetics of CYP P 450 by Using the Infinitesimal Generator Approach

  2018cites this paper
• Out‐compute drug side effects: Focus on cytochrome P450 2D6 modeling

  2018cites this paper
• Advances in drug metabolism and pharmacogenetics research in Australia

  2017cites this paper
• Thermodynamics of camphor migration in cytochrome P450cam by atomistic simulations

  2017cites this paper
• An evidence-based review of the genotoxic and reproductive effects of sulfur mustard

  2017cites this paper
• In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions.

  2017cites this paper
• Increased Expression of CYP2E1 Gene in Gastric Cancer May be a Molecular Marker for Mazandaran Province Population

  2017cites this paper
• Pharmacogenomics of CYP2C9: Functional and Clinical Considerations†

  2017influential citation
• Chapter 6 Summary , discussion and future perspectives

  2017cites this paper
• Single or Multiple Access Channels to the CYP450s Active Site? An Answer from Free Energy Simulations of the Human Aromatase Enzyme.

  2017cites this paper
• Study of cyp2E1 gene RsaI/PstI polymorphisms in patients with gastric cancer in north of Iran

  2016cites this paper
• Predicting Regioselectivity and Lability of Cytochrome P450 Metabolism Using Quantum Mechanical Simulations

  2016cites this paper